Neurological therapies

On this page:

• Belbuca
• Cuvposa^O
• DaTscan^B
• Glatect^O
• Mavenclad^O
• NeuraCeq
• Ocrevus

Belbuca

Medical ingredient:

Buprenorphine Hydrochloride

Indication:

Belbuca is used for the long-term management of pain, when:

• the pain is severe enough to require daily, around-the-clock pain medication
• the doctor determines that other treatment options are not able to effectively treat your pain

For more information, see the Regulatory Decision Summary.

Cuvposa^O

Medical ingredient:

Glycopyrrolate

Indication:

Cuvposa is used for reducing drooling caused by certain health problems. It is for patients that are 3-18 years old.

For more information, see the Regulatory Decision Summary.

DaTscan^B

(new active substance)

Medical ingredient:

Ioflupane (123I)

Indication:

DaTscan is a radioactive diagnostic agent which is used with a special camera to take pictures of the brain. In adult patients who have symptoms of Parkinsonian Syndromes (such as Parkinson's disease), DaTscan is used along with other diagnostic tests to give the doctor more information about their condition.

For more information, see the Regulatory Decision Summary.

Glatect^O

Medical ingredient:

Glatiramer Acetate

Indication:

Glatect is used to treat patients with Relapsing Remitting Multiple Sclerosis (RRMS).

For more information, see the Regulatory Decision Summary.

Mavenclad^O

Medical ingredient:

Cladribine

Indication:

Mavenclad is used to treat adult patients with relapsing-remitting multiple sclerosis (RRMS). Multiple sclerosis (MS) is a disease that affects the brain and spinal cord.

For more information, see the Regulatory Decision Summary.

NeuraCeq

(new active substance)

Medical ingredient:

Florbetaben (18F)

Indication:

NeuraCeq is given to people with memory problems so that doctors can perform a type of brain scan, called a PET scan (Positron Emission Tomography). A NeuraCeq PET scan, along with other brain function tests, can help your doctor determine whether or not you may have β-amyloid plaques in your brain.

For more information, see the Summary Basis of Decision.

Ocrevus

(new active substance)

Medical ingredient:

Ocrelizumab

Indication:

Ocrevus is a prescription medicine used to treat adults with active Relapsing Remitting Multiple Sclerosis (RRMS).

For more information, see the Regulatory Decision Summary.

Health Canada approved 14 new generic drugs for neurological therapies.

Health Canada released nine risk communications for neurological therapies.